NFKB1 and B-cell non-Hodgkin lymphoma: These mRNAs were enriched in pathways previously reported to be associated with B cell lymphoma, such as the PI3K-Akt signaling pathway (Uddin et al., 2006; Yuan et al., 2019) and the NF-κB signaling pathway (Weniger and Kuppers, 2016; Figure 2).